Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
- Germany
- Turkey
- United States
Investment stages
- Pre-Seed
- Seed
Industries
- HealthTech
- Deep Tech
- Biotech
- Climate
- Environment
- Mental Health
- Financial Resilience
- Automation
- Later-Life
- Impact
- Science-for-Impact
About
Zinc is a London-based venture capital firm and venture builder focused on solving developed world's toughest social issues through science-for-impact innovation. Their focus spans healthtech, deep tech, biotech, climate, environment, and mental health across United Kingdom, Germany, Turkey, and the United States. The firm supports founders from pre-seed through seed stages.
Zinc is a London-based venture capital firm and venture builder focused on solving developed world's toughest social issues through science-for-impact innovation. Their focus spans healthtech, deep tech, biotech, climate, environment, and mental health across United Kingdom, Germany, Turkey, and the United States. The firm supports founders from pre-seed through seed stages.
Investment Thesis
Zinc is a pre-seed and seed stage venture capital firm and venture builder deploying capital across science-for-impact sectors including healthtech, deep tech, biotech, climate, environment, mental health, financial resilience, automation, and later-life sectors. They invest through 6-month venture-building programmes bringing together 50 bright minds to find co-founders and build new commercial businesses from scratch. The firm differentiates itself through £70M Science-for-Impact Fund (£46M British Business Bank commitment) and unique venture-builder model creating mission-led businesses at intersection of science, entrepreneurship, and social impact.
Manager's Experience
Founded in 2017. Team of 25 including 5 partners based in London. Backed by Reid Hoffman, LocalGlobe, and Entrepreneurs First. Manages £70M Science-for-Impact Fund with British Business Bank committing up to £46M. Portfolio of 102+ investments across United Kingdom, Germany, Turkey, and United States. Notable exit: Parla. Runs 6-month venture-building programmes bringing together 50 bright minds to find co-founders and build scalable commercial impact-led businesses solving developed world's toughest social issues across healthtech, deep tech, biotech, climate, environment, and mental health. Notable portfolio includes Serenatis Bio, Tangent, SignaCor, Clyde Hydrogen, and Green Wing.
Team
Ella Goldner-Co-Founder
Paul Kirby-Co-Founder
Saul Klein-Co-Founder
Julia Ross-Co-Founder & Director Inflection
Portfolio
Vira Health
Tandem
Pexxi
BelleVie
Untangle
Whering
TaskHer
LiberEat
BioHarv